z-logo
open-access-imgOpen Access
Azathioprine Metabolite Measurements Are not Useful for Following Treatment of Autoimmune Hepatitis in Alaska Native and other Non-Caucasian People
Author(s) -
Elizabeth D. Ferucci,
Kathy J. Hurlburt,
Marlyn J. Mayo,
Stephen Livingston,
Heike Deubner,
James Gove,
Julia Plotnik,
Brian J. McMahon
Publication year - 2011
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2011/137476
Subject(s) - azathioprine , thiopurine methyltransferase , leukopenia , medicine , gastroenterology , autoimmune hepatitis , genotype , immunology , pharmacology , hepatitis , toxicity , disease , biology , genetics , gene
In autoimmune hepatitis (AIH) patients treated with azathioprine, the utility of measuring thiopurine methyltransferase (TPMT) and azathioprine metabolites has been limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom